[29P-am] Radioactivity measurement/Synthesis of labelled compounds and their metabolism 1/Radiopharmaceuticals/Protection and control of radiation/Others

Fri. Mar 29, 2024 8:30 AM - 12:00 PM [Poster] Exhibition Hall AB (1F)

+Add all to schedule

[29P-am163S] Evaluation of an ²¹¹At-labeled peptide targeting melanoma as a targeted α-therapy agent

○Megumi Uchiyama¹, Hiroyuki Suzuki¹, Shoko Tanaka¹, Saki Yamashita¹, Kento Kannaka¹, Tomoya Uehara¹ (1. Grad.Sch.Pharm.Sci.,Chiba Univ.)

[29P-am164S] ²¹¹At-labeled PSMA derivative for reducing radioactivity in the kidney

○Taichi Muto¹, Tomoki Yamashita², Kento Kannaka², Hiroyuki Suzuki², Tomoya Uehara² (1. Chiba Univ., 2. Grad. Sch. Pharm. Sci, Chiba Univ.)

[29P-am165S] Fundamental evaluation of the relationship between albumin-binding and tumor accumulation of PSMA-targeted radiopharmaceuticals

○Nobuki Kazuta¹, Hiroyuki Watanabe¹, Masahiro Ono¹ (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)

[29P-am166] Evaluation of the efficacy for a PET imaging probe targeting STAT3

○Anna Miyazaki¹, Yurika Iio¹, Yasukazu Kanai¹, Keita Wakamori¹, Serina Mizuguchi¹, Mikiya Futatsugi¹, Fuko Hirano¹, Naoya Kondo¹, Takashi Temma¹ (1. Grad. Sch. Pharm. Sci., Osaka Med. Pharm. Univ.)

[29P-am167S] Synthesis and evaluation of SPECT imaging probes targeting STAT3

○Maiko Hayashi¹, Anna Miyazaki¹, Hiroto Takahashi¹, Keita Wakamori¹, Serina Mizuguchi¹, Mikiya Futatsugi¹, Fuko Hirano¹, Naoya Kondo¹, Takashi Temma¹ (1. Pharm. Sci., Osaka Med. Pharm. Univ.)

[29P-am168S] Development and initial evaluation of novel functional nano particles for accelerated blood clearance (ABC) phenomenon evasion.

○Reo Takahashi¹, Narumi Endo¹, Kotaro Anzai¹, Yuichiro Tanaka¹, Yumi Yamamoto¹, Yohei Saito¹, Akira Makino², Yasushi Kiyono², Fumihiko Yamamoto¹ (1. Facility of Pharmaceutical science, Tohoku Med. Pharm. Univ., 2. Biomedical Imaging Research Center, Fukui Univ.)

[29P-am169S] Evaluation of the effect of lipid charge on tumor accumulation of lipid-styrene maleic acid copolymer nanodiscs

○Tomoya Fukada¹, Kohei Sano¹, Masayuki Munekane², Toshihide Yamasaki¹, Masafumi Tanaka¹, Takahiro Mukai¹ (1. Kobe Pharm. Univ., 2. Grad. Sch. Med. Sci., Kanazawa Univ.)

[29P-am170] Development of heparanase-targeted radiopharmaceuticals to detect vulnerable plaques in atherosclerosis

○Kohei Sano¹, Shiho Tanaka¹, Miyu Kohira¹, Naoto Sasaki¹, Toru Tanaka¹, Satomi Nadanaka¹, Toshihide Yamasaki¹, Yoshiyuki Rikitake¹, Hiroshi Kitagawa¹, Masayori Hagimori², Takahiro Mukai¹ (1. Kobe Pharm. Univ., 2. Sch. Pharm., Mukogawa Women's Univ.)

[29P-am171S] Development of a radiolabeled probe to evaluate the in vivo behavior of hypochlorous acid non-invasively

○Terumi Sakane¹, Risa Azuma¹, Toshihide Yamasaki¹, Kohei Sano¹, Takahiro Mukai¹ (1. Kobe Pharm. Univ.)

[29P-am172] Development of a novel σ-2 receptor ligand, MILV, and basic evaluation as an imaging probe

○Takashi Kozaka¹, Yoji Kitamura¹, Kazuma Ogawa², Hiroyuki Kimura¹ (1. ReCEMHD, Kanazawa Univ., 2. Inst. Frontier Sci. Initiative, Kanazawa Univ.)

[29P-am173S] Development of Cherenkov-activated imaging agents

○Yuri Endo¹, Atsushi Hirose¹, Yoshinori Kato¹ (1. Hoshi Univ.)

[29P-am174] Radiation education for junior and senior high school students using the measuring of naturally occurring radioactive materials and gamification tool

○Fujino Hideki¹, Sato Yoshiko², Shiraishi Shugo¹, Hayashi Takunari¹, Sakai Shuhei¹ (1. Sch. Pharm., Hyogo Medical Univ., 2. Junior and Senior High Sch., Wakayama Shin-ai )

[29P-am175S] Development a novel⁴⁰ K quantification to prevent medical accident caused by potassium overdose

○Taisei Hayashi¹, Miho Tkahashi¹, Tsutomu Yodoshi², Syuhei Sakai¹, Hideki Fujino^1,2 (1. Sch. Pharm., Hyogo Medical Univ., 2. Grad. Sch. Pharm., Hyogo Medical Univ.)

[29P-am176] Proposal of inspection method for radiation measuring instruments using commercial regents

○Shuhei Sakai¹, Hideki Fujino¹ (1. Sch. Pharm., Hyogo Medical Univ.)

Session information